WALTHAM, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. announced today that Paul M. Meister, chairman of the board, and certain executive officers, including Marijn E. Dekkers, chief executive officer, have adopted stock-trading programs under Securities and Exchange Commission (SEC) Rule 10b5-1 covering the future sale of company stock. Mr. Meister has adopted a plan for the sale of up to 2,250,000 shares. Mr. Dekkers has adopted a plan for the sale of up to 1,046,660 shares, which he would acquire upon the exercise of a stock option that was granted when he joined the company in 2000 and expires in July 2007.
After selling these shares, Mr. Meister would own shares or hold options totaling 2,250,400 shares. Mr. Dekkers would own shares, or share equivalents, and hold options totaling 2,935,378 shares.
These trading programs are based on SEC Rule 10b5-1, which protects company executives from possible claims of insider trading by permitting them to buy or sell a predetermined amount of their company’s shares, as set forth in a planned acquisition or divestiture program that was adopted when the insider did not possess any material non-public information.
About Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual sales of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.
Media Contact Information: Lori Gorski Phone: 781-622-1242 E-mail: lori.gorski@thermofisher.com Website: http://www.thermofisher.com Investor Contact Information: Ken Apicerno Phone: 781-622-1111 E-mail: ken.apicerno@thermofisher.com
Thermo Fisher Scientific Inc.
CONTACT: Media Contact: Lori Gorski, +1-781-622-1242,lori.gorski@thermofisher.com, or Investor Contact: Ken Apicerno,+1-781-622- 1111, ken.apicerno@thermofisher.com
Web site: http://www.thermofisher.com/
Company News On-Call: http://www.prnewswire.com/comp/877850.html/
